• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Immune Checkpoint Inhibitors' Effects on Calcified Aortic Plaques in Melanoma Survivors: A Retrospective Cohort Study.

作者信息

Turker Isik, Nair Sangeeta, Terry James G, Huang Shi, Carr John Jeffrey, Moslehi Javid J, Gupta Deepak K, Alexander Matthew R, Johnson Douglas B

出版信息

JACC CardioOncol. 2023 Jun 27;5(4):536-538. doi: 10.1016/j.jaccao.2023.05.005. eCollection 2023 Aug.

DOI:10.1016/j.jaccao.2023.05.005
PMID:37614587
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10443105/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/248b/10443105/886fe4d0fcab/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/248b/10443105/886fe4d0fcab/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/248b/10443105/886fe4d0fcab/gr1.jpg

相似文献

1
Immune Checkpoint Inhibitors' Effects on Calcified Aortic Plaques in Melanoma Survivors: A Retrospective Cohort Study.免疫检查点抑制剂对黑色素瘤幸存者钙化主动脉斑块的影响：一项回顾性队列研究。
JACC CardioOncol. 2023 Jun 27;5(4):536-538. doi: 10.1016/j.jaccao.2023.05.005. eCollection 2023 Aug.
2
Immune checkpoint inhibitor (anti-CTLA-4, anti-PD-1) therapy alone versus immune checkpoint inhibitor (anti-CTLA-4, anti-PD-1) therapy in combination with anti-RANKL denosumuab in malignant melanoma: a retrospective analysis at a tertiary care center.免疫检查点抑制剂（抗CTLA-4、抗PD-1）单药治疗与免疫检查点抑制剂（抗CTLA-4、抗PD-1）联合抗RANKL地诺单抗治疗恶性黑色素瘤的疗效比较：三级医疗中心的回顾性分析
Melanoma Res. 2018 Aug;28(4):341-347. doi: 10.1097/CMR.0000000000000459.
3
PD-L1 Tumor Expression as a Predictive Biomarker of Immune Checkpoint Inhibitors' Response and Survival in Advanced Melanoma Patients in Brazil.程序性死亡配体1（PD-L1）肿瘤表达作为巴西晚期黑色素瘤患者免疫检查点抑制剂反应和生存的预测生物标志物。
Diagnostics (Basel). 2023 Mar 9;13(6):1041. doi: 10.3390/diagnostics13061041.
4
Vitiligo-like leukoderma as an indicator of clinical response to immune checkpoint inhibitors in late-stage melanoma patients.白癜风样白化病作为晚期黑色素瘤患者对免疫检查点抑制剂临床反应的指标。
J Cancer Res Clin Oncol. 2022 Sep;148(9):2529-2538. doi: 10.1007/s00432-021-03811-3. Epub 2021 Sep 30.
5
Use of immune checkpoint inhibitors prolonged overall survival in a Japanese population of advanced malignant melanoma patients: Retrospective single institutional study.免疫检查点抑制剂的使用延长了晚期恶性黑色素瘤日本患者的总生存期：回顾性单机构研究。
J Dermatol. 2018 Nov;45(11):1337-1339. doi: 10.1111/1346-8138.14637. Epub 2018 Sep 11.
6
Health-related quality of life of long-term advanced melanoma survivors treated with anti-CTLA-4 immune checkpoint inhibition compared to matched controls.与匹配对照相比，接受抗 CTLA-4 免疫检查点抑制治疗的长期晚期黑色素瘤幸存者的健康相关生活质量。
Acta Oncol. 2021 Jan;60(1):69-77. doi: 10.1080/0284186X.2020.1818823. Epub 2020 Sep 14.
7
Problem-based review: Immune-mediated complications of 'Checkpoint Inhibitors' for the Acute Physician.基于问题的综述：急性病医生需了解的“免疫检查点抑制剂”免疫介导并发症
Acute Med. 2017;16(1):21-24.
8
An immunotherapy survivor population: health-related quality of life and toxicity in patients with metastatic melanoma treated with immune checkpoint inhibitors.免疫治疗幸存者人群：接受免疫检查点抑制剂治疗的转移性黑色素瘤患者的健康相关生活质量和毒性。
Support Care Cancer. 2020 Feb;28(2):561-570. doi: 10.1007/s00520-019-04818-w. Epub 2019 May 14.
9
Suitability of tumor-associated antibodies as predictive biomarker for response to immune checkpoint inhibitors in patients with melanoma: a short report.肿瘤相关抗体作为预测黑色素瘤患者免疫检查点抑制剂反应的生物标志物的适用性：一份简短报告。
J Immunother Cancer. 2023 Feb;11(2). doi: 10.1136/jitc-2022-006467.
10
New Zealand national retrospective cohort study of survival outcomes of patients with metastatic melanoma receiving immune-checkpoint inhibitors.新西兰转移性黑色素瘤患者接受免疫检查点抑制剂治疗生存结局的全国性回顾性队列研究。
Asia Pac J Clin Oncol. 2023 Feb;19(1):179-186. doi: 10.1111/ajco.13801. Epub 2022 Jun 10.

引用本文的文献

1
Onset and progression of atherosclerosis in patients with melanoma treated with immune checkpoint inhibitors.接受免疫检查点抑制剂治疗的黑色素瘤患者动脉粥样硬化的发病及进展
J Immunother Cancer. 2025 Apr 24;13(4):e011226. doi: 10.1136/jitc-2024-011226.
2
Chronic immune-related adverse events arising from immune checkpoint inhibitors: an update.免疫检查点抑制剂相关的慢性免疫相关不良事件：最新进展。
J Immunother Cancer. 2024 Jul 4;12(7):e008591. doi: 10.1136/jitc-2023-008591.
3
Immunotherapy-Associated Atherosclerosis: A Comprehensive Review of Recent Findings and Implications for Future Research.

本文引用的文献

1
Two-faced Janus: the dual role of macrophages in atherosclerotic calcification.双面雅努斯：巨噬细胞在动脉粥样硬化钙化中的双重作用。
Cardiovasc Res. 2022 Oct 21;118(13):2768-2777. doi: 10.1093/cvr/cvab301.
2
Association Between Immune Checkpoint Inhibitors With Cardiovascular Events and Atherosclerotic Plaque.免疫检查点抑制剂与心血管事件及动脉粥样硬化斑块的关系。
Circulation. 2020 Dec 15;142(24):2299-2311. doi: 10.1161/CIRCULATIONAHA.120.049981. Epub 2020 Oct 2.
3
Scoring of coronary artery calcium scans: history, assumptions, current limitations, and future directions.
免疫疗法相关动脉粥样硬化：近期研究结果及对未来研究启示的全面综述
Curr Treat Options Cardiovasc Med. 2023;25(12):715-735. doi: 10.1007/s11936-023-01024-0. Epub 2023 Dec 15.
4
Immune checkpoint inhibitor-related myocarditis: current understanding and potential diagnostic and therapeutic strategies.免疫检查点抑制剂相关心肌炎：当前认识和潜在的诊断及治疗策略。
Expert Opin Drug Saf. 2023 Jul-Dec;22(10):909-919. doi: 10.1080/14740338.2023.2254218. Epub 2023 Sep 4.
冠状动脉钙化扫描评分：历史、假设、当前局限性及未来方向。
Atherosclerosis. 2015 Mar;239(1):109-17. doi: 10.1016/j.atherosclerosis.2014.12.040. Epub 2015 Jan 2.
4
Degree of carotid plaque calcification in relation to symptomatic outcome and plaque inflammation.颈动脉斑块钙化程度与症状性结局及斑块炎症的关系
J Vasc Surg. 2004 Aug;40(2):262-9. doi: 10.1016/j.jvs.2004.04.025.
5
Aortic plaque morphology and vascular events: a follow-up study in patients with ischemic stroke. FAPS Investigators. French Study of Aortic Plaques in Stroke.主动脉斑块形态与血管事件：一项对缺血性中风患者的随访研究。FAPS研究人员。法国中风主动脉斑块研究。
Circulation. 1997 Dec 2;96(11):3838-41. doi: 10.1161/01.cir.96.11.3838.